PNT - POINT Biopharma Global GAAP EPS of -$0.16 beats by $0.15
2023-05-15 09:46:44 ET
- POINT Biopharma Global press release ( NASDAQ: PNT ): Q1 GAAP EPS of -$0.16 beats by $0.15 .
- As of March 31, 2023, POINT had approximately $519.2 million in cash, cash equivalents, and investments, which is anticipated to fund operations into 2026.
For further details see:
POINT Biopharma Global GAAP EPS of -$0.16 beats by $0.15